A substantial increase in LRG1 expression has been reported in cancer and diabetes, both responsible for a great burden of morbidity and mortality worldwide, but also in infections, cardiovascular, kidney, lung, neurological and autoimmune disorders. Here, LRG1 is linked to diabetes mellitus.